Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK2 | P24941 | 16/20 | 0.73 |
| ▸ | CCNE2 | O96020 | 6/20 | 0.73 |
| ▸ | CCNE1 | P24864 | 6/20 | 0.73 |
| ▸ | CDK9 | P50750 | 13/20 | 0.71 |
| ▸ | CDK7 | P50613 | 4/20 | 0.71 |
| ▸ | CCNT1 | O60563 | 4/20 | 0.71 |
| ▸ | CCNH | P51946 | 3/20 | 0.71 |
| ▸ | MNAT1 | P51948 | 2/20 | 0.71 |
| ▸ | CCNA1 | P78396 | 2/20 | 0.71 |
| ▸ | HDAC3 | O15379 | 3/20 | 0.68 |
| ▸ | HDAC4 | P56524 | 3/20 | 0.68 |
| ▸ | HDAC1 | Q13547 | 3/20 | 0.68 |
| ▸ | HDAC7 | Q8WUI4 | 3/20 | 0.68 |
| ▸ | HDAC2 | Q92769 | 3/20 | 0.68 |
| ▸ | HDAC10 | Q969S8 | 3/20 | 0.68 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.68 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.68 |
| ▸ | HDAC6 | Q9UBN7 | 3/20 | 0.68 |
| ▸ | HDAC9 | Q9UKV0 | 3/20 | 0.68 |
| ▸ | HDAC5 | Q9UQL6 | 3/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23230178 | 0.86 | CDK2 (0.76) | CDK2CCNE2CCNE1CDK9CDK7 | |
| SCHEMBL24528979 | 0.86 | CDK2 (0.79) | CDK2CCNE2CCNE1CDK9CDK7 | |
| SCHEMBL24528750 | 0.85 | CDK2 (0.84) | CDK2CCNE2CCNE1CDK9CDK7 | |
| SCHEMBL4994410 | 0.85 | CDK2 (0.83) | CDK2CCNE2CCNE1CDK9CDK7 | |
| SCHEMBL20905302 | 0.84 | CDK2 (1.00) | CDK2CCNE2CCNE1CDK9CDK7 | |
| SCHEMBL24758127 | 0.84 | CDK2 (0.79) | CDK2CCNE2CCNE1CDK9CDK7 | |
| SCHEMBL4215831 | 0.84 | CDK2 (0.79) | CDK2CCNE2CCNE1CDK9CDK7 | |
| SCHEMBL18613589 | 0.84 | CDK2 (0.84) | CDK2CCNE2CCNE1CDK9CDK7 | |
| SCHEMBL17141895 | 0.83 | CDK2 (1.00) | CDK2CCNE2CCNE1CDK9CDK7 | |
| SCHEMBL24758393 | 0.83 | CDK2 (0.83) | CDK2CCNE2CCNE1CDK9CDK7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220184104-A1 | SILANOL BASED THERAPEUTIC PAYLOADS | BLINKBIO INC (US) | 2022-06-16 | — | — | US | disclosed |
| US-20210161921-A1 | Silanol Based Therapeutic Payloads | BLINKBIO, INC. | 2021-06-03 | — | — | US | disclosed |
| US-10716801-B2 | Silanol based therapeutic payloads | BLINKBIO, INC. (US) | 2020-07-21 | — | — | US | disclosed |
| US-20190183913-A1 | Silanol Based Therapeutic Payloads | BLINKBIO INC (US) | 2019-06-20 | — | — | US | disclosed |
| US-10293053-B2 | Silanol based therapeutic payloads | BLINKBIO, INC. (US) | 2019-05-21 | — | — | US | disclosed |
| US-20190111142-A1 | Silanol Based Therapeutic Payloads | BLINKBIO, INC. (US) | 2019-04-18 | — | — | US | disclosed |
| US-20180200273-A1 | Silanol Based Therapeutic Payloads | BLINKBIO INC (US) | 2018-07-19 | — | — | US | disclosed |
| WO-2017214491-A1 | SILANOL BASED THERAPEUTIC PAYLOADS | BLINKBIO, INC. (US) | 2017-12-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190183913-A1 | Silanol Based Therapeutic Payloads | CD47, CD4, BST2 | CDK2 3576/4885CCNE2 1602/4885CCNE1 632/4885 |
| US-20210161921-A1 | Silanol Based Therapeutic Payloads | CD47, CD4, BST2 | CDK2 3576/4885CCNE2 1602/4885CCNE1 632/4885 |
| US-10716801-B2 | Silanol based therapeutic payloads | CD47, CD4, BST2 | CDK2 3576/4885CCNE2 1602/4885CCNE1 632/4885 |
| US-20180200273-A1 | Silanol Based Therapeutic Payloads | CD47, CD4, BST2 | CDK2 3576/4885CCNE2 1602/4885CCNE1 632/4885 |
| US-10293053-B2 | Silanol based therapeutic payloads | CD47, CD4, BST2 | CDK2 3576/4885CCNE2 1602/4885CCNE1 632/4885 |
| US-20190111142-A1 | Silanol Based Therapeutic Payloads | CD47, CD4, BST2 | CDK2 3576/4885CCNE2 1602/4885CCNE1 632/4885 |
| US-20220184104-A1 | SILANOL BASED THERAPEUTIC PAYLOADS | CD47, CD4, BST2 | CDK2 3576/4885CCNE2 1602/4885CCNE1 632/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.